Financials
- Market Capitalization 42.8 M
- Employee 20
- Founded 1971
- CEO N/A
- Website www.verupharma.com
- Headquarter Wisconsin, United States
- FIGI BBG000G12J78
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-5.23
Fiyat/satışlar oranı
—
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 4297 | CNTX Context Therapeutics Inc. - Common Stock | 0.48 USD | -4.00% | -7.69% | -21.31% | -46.07% | 44.10 M USD | ||
| 4300 | MCRB Seres Therapeutics, Inc. - Common Stock | 4.54 USD | -0.44% | -0.66% | -8.84% | -44.84% | 45.13 M USD | ||
| 4310 | KPTI Karyopharm Therapeutics Inc. - Common Stock | 1.85 USD | -5.61% | -5.61% | -75.17% | -80.81% | 41.96 M USD | ||
| 4315 | TVGN Tevogen Bio Holdings Inc. - Common Stock | 6.44 USD | -4.59% | -2.28% | +41.23% | +592.47% | 41.93 M USD |